StonvexLoading…
StonvexStonvexStonvexCore line items from LXU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $169.49M | $615.21M | $450.16M | $294.73M |
Operating Income | $23.16M | $57.27M | $30.59M | $14.96M |
Net Income | $19.68M | $24.61M | $8.48M | $3.01M |
EPS (Diluted) | $0.27 | $0.34 | $0.12 | $0.02 |
Total Assets | $1.19B | $1.17B | $1.15B | $1.13B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $20.64M | $19.51M | $27.95M | $5.61M |
Free Cash Flow OCF − CapEx | $34.82M | $18.06M | $21.25M | $-14.35M |
Shares Outstanding | 73.06M | 72.36M | 72.25M | 72.14M |